|
|
|
Insider
Information: |
Miller Michael Patrick |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
73,419 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,568,219 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
73,419 |
|
|
Total
Value |
$2,568,219 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
40.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vivus Inc |
VVUS |
Chief Commercial Officer |
2012-07-18 |
7,943 |
2012-06-12 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, US Commercial |
2020-03-12 |
22,118 |
|
0 |
Premium* |
|
Puma Biotechnology Inc |
PBYI |
Director |
2023-11-07 |
43,358 |
2018-06-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PBYI |
Puma Biotechnology Inc |
Director |
|
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,482 |
5,482 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-06-14 |
4 |
AS |
$176.53 |
$35,306 |
D/D |
(200) |
25,972 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-07-13 |
4 |
AS |
$179.15 |
$35,830 |
D/D |
(200) |
25,772 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-08-14 |
4 |
AS |
$175.70 |
$35,140 |
D/D |
(200) |
25,572 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-09-14 |
4 |
AS |
$165.20 |
$33,040 |
D/D |
(200) |
25,372 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-10-12 |
4 |
AS |
$158.46 |
$31,692 |
D/D |
(200) |
25,172 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2018-11-13 |
4 |
AS |
$149.27 |
$29,854 |
D/D |
(200) |
24,972 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-02-25 |
4 |
D |
$126.25 |
$66,660 |
D/D |
(528) |
24,517 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-02-26 |
4 |
D |
$127.76 |
$52,893 |
D/D |
(414) |
24,103 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
32,503 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-03-05 |
4 |
D |
$135.82 |
$201,149 |
D/D |
(1,481) |
31,022 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-06-05 |
4 |
D |
$130.40 |
$16,039 |
D/D |
(123) |
31,039 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2019-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,423 |
24,905 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2019-12-09 |
4 |
AS |
$149.12 |
$223,680 |
D/D |
(1,500) |
29,571 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2020-02-13 |
4 |
AS |
$142.18 |
$213,270 |
D/D |
(1,500) |
26,571 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2020-02-25 |
4 |
D |
$127.25 |
$67,443 |
D/D |
(530) |
26,041 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2020-03-05 |
4 |
D |
$124.50 |
$301,664 |
D/D |
(2,423) |
23,618 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
EVP, US Commercial |
|
2020-03-12 |
4 |
AS |
$102.17 |
$153,255 |
D/D |
(1,500) |
22,118 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,748 |
50,653 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
27,858 |
78,511 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2022-03-16 |
4 |
S |
$2.80 |
$71,792 |
D/D |
(25,653) |
52,858 |
0 |
% |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
79,858 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2022-08-09 |
4 |
S |
$3.55 |
$88,793 |
D/D |
(25,000) |
54,858 |
0 |
% |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2023-06-13 |
4 |
AS |
$3.45 |
$46,630 |
D/D |
(13,500) |
41,358 |
0 |
% |
|
PBYI |
Puma Biotechnology Inc |
Director |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
68,358 |
0 |
- |
|
76 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|